PHAR logo

Pharming Group N.V. ADS, each representing 10 ordinary shares


PHAR: Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on developing and producing human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. The revenue is generated from the United States.


Show PHAR Financials

Consumer Interest
SEC Filings

Recent trades of PHAR by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by PHAR's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of PHAR in WallStreetBets Daily Discussion


Recent insights relating to PHAR

CNBC Recommendations

Recent picks made for PHAR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PHAR

Corporate Flights

Flights by private jets registered to PHAR